Immunohistochemical absence of CD21 membrane receptor in nasopharyngeal carcinoma cells infected by Epstein-Barr virus in Spanish patients

被引:10
|
作者
Burgos, JS [1 ]
Vera-Sempere, FJ
机构
[1] Univ Autonoma Madrid, Fac Ciencias, CSIC, Ctr Biol Mol Severo Ochoa,CV Lab 203, E-28049 Madrid, Spain
[2] Univ Valencia, Hosp La Fe, Sch Med, Serv Pathol, Valencia, Spain
来源
LARYNGOSCOPE | 2000年 / 110卷 / 12期
关键词
Epstein-Barr virus; nasopharyngeal carcinoma; non-isotopic in situ hybridization; PCR;
D O I
10.1097/00005537-200012000-00020
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives/Hypothesis: The aim of this study was to analyze the relevance of the CD21 membrane receptor in nasopharyngeal carcinoma (NPC). CD21 is implicated in the introduction of the Epstein-Barr virus (EBV) genome into epithelial cells and B lymphocytes. Study Design: Immunohistochemical analysis of CD21 in NPC. Methods: Paraffin-embedded samples of NPC of different histological types with demonstrated presence of EBV were analyzed for CD21 expression using immunohistochemistry. Results: We detected EBV by non-isotopic in situ hybridization (NISH) and nested polymerase chain reaction (PCR) in 100% of samples, regardless of histological type, supporting the previous view that all the types of NPC are variants of an EBV-associated malignancy. CD21 was not detected in NPC, and this absence was a typical feature in our data group. Conclusions: The loss of the CD21 membrane receptor could be one of the immunophenotypical changes of the neoplastic cells that occur in the evolution of the NPC malignancy.
引用
下载
收藏
页码:2081 / 2084
页数:4
相关论文
共 50 条
  • [1] The role of the Epstein-Barr Virus receptor CD21 in Multiple Sclerosis
    Toepfner, Nicole
    Cepok, Sabine
    Grummel, Verena
    Hemmer, Bernhard
    JOURNAL OF NEUROIMMUNOLOGY, 2012, 242 (1-2) : 47 - 51
  • [2] CD21 (Complement Receptor 2) Is the Receptor for Epstein-Barr Virus Entry into T Cells
    Smith, Nicholas A.
    Coleman, Carrie B.
    Gewurz, Benjamin E.
    Rochford, Rosemary
    JOURNAL OF VIROLOGY, 2020, 94 (11)
  • [3] Epstein-Barr virus and CD21 expression in gastrointestinal tumors
    Kim, YS
    Paik, SR
    Kim, HK
    Yeom, BW
    Kim, I
    Lee, D
    PATHOLOGY RESEARCH AND PRACTICE, 1998, 194 (10) : 705 - 711
  • [4] Absence of p53 alterations in nasopharyngeal carcinoma Spanish patients with Epstein-Barr virus infection
    Burgos, JS
    VIRUS GENES, 2003, 27 (03) : 263 - 268
  • [5] Epstein-Barr virus infection of human gastric carcinoma cells: Implication of the existence of a new virus receptor different from CD21
    Yoshiyama, H
    Imai, S
    Shimizu, N
    Takada, K
    JOURNAL OF VIROLOGY, 1997, 71 (07) : 5688 - 5691
  • [6] THE EPSTEIN-BARR VIRUS AND NASOPHARYNGEAL CARCINOMA
    TARR, KL
    GLASER, R
    MICROBIAL PATHOGENESIS, 1989, 7 (01) : 11 - 14
  • [7] Epstein-Barr virus and nasopharyngeal carcinoma
    Young, Lawrence S.
    Dawson, Christopher W.
    CHINESE JOURNAL OF CANCER, 2014, 33 (12) : 581 - 590
  • [8] ROLE OF THE CD21 ANTIGEN IN LYMPHOCYTE-TRANSFORMATION BY EPSTEIN-BARR VIRUS
    BOYD, AW
    FECONDO, J
    IMMUNOLOGY AND CELL BIOLOGY, 1988, 66 : 159 - 165
  • [9] EXPRESSION OF THE EPSTEIN-BARR VIRUS (EBV) RECEPTOR ON THE SURFACE OF CELLS INFECTED WITH EBV DERIVED FROM NASOPHARYNGEAL CARCINOMA
    TAKIMOTO, T
    UMEDA, R
    ACTA VIROLOGICA, 1989, 33 (04) : 314 - 319
  • [10] SUPERINFECTION OF EPITHELIAL NASOPHARYNGEAL CARCINOMA CELLS WITH EPSTEIN-BARR VIRUS
    GLASER, R
    THE, GD
    LENOIR, G
    HO, JHC
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1976, 73 (03) : 960 - 963